|
03/30/2021
|
Summary ToggleEledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Operating and Financial Results
|
|
03/23/2021
|
Summary ToggleEledon Pharmaceuticals to Release Fourth Quarter and Full-Year Financial Results on Tuesday, March 30
|
|
03/15/2021
|
Summary ToggleEledon Pharmaceuticals Strengthens Leadership Team with Chief Medical Officer and Chief Financial Officer Hires
|
|
03/02/2021
|
Summary ToggleEledon Pharmaceuticals to Present at H.C. Wainwright Global Life Sciences Conference
|
|
02/17/2021
|
Summary ToggleEledon Pharmaceuticals to Present at 10th Annual SVB Leerink Global Healthcare Conference
|
|
01/19/2021
|
Summary ToggleEledon Pharmaceuticals to Participate in the Virtual Noble Capital Markets' Seventeenth Annual Investor / Equity Conference
|
|
01/04/2021
|
Summary ToggleNovus Therapeutics Announces Name Change to Eledon Pharmaceuticals; Provides Corporate Update and Outlook
|
|
12/22/2020
|
Summary ToggleNovus Therapeutics Announces Results of Special Meeting of Stockholders
|
|
12/09/2020
|
Summary ToggleNovus Therapeutics Appoints June Lee, M.D., to Board of Directors
|
|
11/16/2020
|
Summary ToggleNovus Therapeutics Reports Third Quarter 2020 Financial Results
|
